Abstract
Early liver transplantation (LT) is an emerging therapy for acute severe alcoholic hepatitis (AH)
in fact recent data show that alcoholic‐liver disease is the predominant driver of cirrhosis‐related mortality among US adults aged 25 to 34.(1) Because multiple small studies have demonstrated that "highly selected" AH patients have comparable one and three‐year survival to those with chronic liver disease (CLD) in receipt of LT
there is increasing momentum to waive the usual expectation of demonstrated alcohol abstinence prior to transplantation.
This article is protected by copyright. All rights reserved
https://ift.tt/2Co3JSt
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.